Skip to main content
. 2021 Apr 9;7(1):e12164. doi: 10.1002/trc2.12164

TABLE 1.

Demographic and clinical characteristics of Hispanic and non‐Hispanic White groups by clinical diagnostic group (N = 1843)

Overall Cognitively unimpaired MCI Dementia
Hispanic N = 1193 Non‐Hispanic White N = 650 Hispanic N = 711 Non‐Hispanic White N = 184 Hispanic N = 325 Non‐Hispanic White N = 115 Hispanic N = 157 Non‐Hispanic White N = 351
Age, years 67 ± 9* 74 ± 8 63 ± 8* 72 ± 8 70 ± 9* 73 ± 9 75 ± 8 75 ± 9
Female, N (%) 840 (70%)* 358 (55%) 515 (72%)* 117 (64%) 223 (69%)* 52 (45%) 102 (65%)* 189 (54%)
Education, years 10 ± 5* 15 ± 3 10 ± 5* 16 ± 2 10 ± 4* 15 ± 3 10 ± 5* 15 ± 3
BMI, m/kg2 31 ± 6* 27 ± 4 31 ± 7* 27 ± 4 31 ± 6* 28 ± 4 29 ± 5* 26 ± 4
Blood pressure, mmHg
Systolic 139 ± 21* 134 ± 18 137 ± 21* 130 ± 27 139 ± 19 135 ± 18 144 ± 21* 135 ± 18
Diastolic 78 ± 12* 76 ± 11 79 ± 12 74 ± 10 76 ± 11 76 ± 11 76 ± 11 76 ± 11
Diabetes, N (%) 398 (33%)* 64 (10%) 230 (32%)* 14 (8%) 112 (34%)* 17 (15%) 56 (36%)* 33(9%)
Presence of APOE ε4 allele, N (%) 247 (21%)* 309 (48%) 130 (18%) 38 (21%) 58 (18%)* 45 (39%) 59 (38%)* 226 (64%)
CDR Global, N (%)
0 737(62%) 194 (30%) 711(100%) 183 (99%) 26 (8%) 11 (10%) 0 (0%) 0 (0%)
0.5 377 (32%) 225 (35%) 0 (0%) 1 (1%) 298 (92%) 103 (90%) 79 (50%) 121 (34%)
≥1 79 (7%) 231 (36%) 0 (0%) 0 (0%) 1 (< 1%) 1 (< 1%) 78 (50%) 230 (66%)
Serum t‐tau, median (quartile 1, quartile 3) 0.3 (0.1, 0.4)* 0.3 (0.2, 0.6) 0.3 (0.1, 0.4) 0.2 (0.1, 0.4) 0.3 (0.1, 0.4)* 0.2 (0.1, 0.4) 0.4 (0.2, 0.6) 0.4 (0.3, 0.6)
Serum NfL median (quartile 1, quartile 3) 17 (12, 26)* 28 (20, 39) 15 (11, 21)* 22 (17, 31) 20 (14, 29)* 24 (17, 35) 31 (22, 50) 33 (24, 45)
Serum GFAP median (quartile 1, quartile 3) 155 (110, 224)* 344 (203, 488) 134 (98, 186)* 206 (145, 367) 174 (120, 249)* 253 (175, 380) 279 (182, 432)* 429 (308, 591)
Serum UCHL1 median (quartile 1, quartile 3) 28 (22, 38)* 36 (28, 51) 27 (22, 37)* 33 (24, 44) 29 (22, 38)* 35 (26, 50) 34 (26, 44)* 39 (30, 56)
Serum YKL‐40 median (quartile 1, quartile 3) 60,645 (37,681, 109,885)* 49,005 (31,140, 82,929) 55,126 (35,181, 101,850)* 41,825 (27,811, 74,587) 64,210 (38,685, 111,221)* 45,589 (29,075, 67,417) 83,807 (55,101, 150,856)* 55,437 (33,577, 91,645)
Serum sCD14 median (quartile 1, quartile 3) 1306 (1163, 1506)* 1422 (1221, 1636) 1299 (1154, 1466)* 1422 (1226, 1591) 1324 (1167, 1553) 1349 (1186, 1524) 1347 (1182, 1623)* 1452 (1247, 1676)
MMSE 26 ± 4* 25 ± 4 28 ± 2* 29 ± 0.9 26 ± 3* 28 ± 2 21 ± 5* 22 ± 4
WMS LM I 30 ± 11* 32 ± 16 34 ± 9* 44 ± 9 27 ± 10* 30 ± 11 16 ± 11 14 ± 9
WMS LM 2 17 ± 9 17 ± 12 20 ± 7* 27 ± 7 15 ± 8 16 ± 9 6 ± 7* 3 ± 5
Animal Fluency 15 ± 5* 14 ± 6 16 ± 4* 18 ± 4 14 ± 4* 16 ± 6 10 ± 4* 11 ± 5
Trails A, seconds to complete 57 ± 32* 51 ± 30 49 ± 24* 36 ± 11 62 ± 33* 40 ± 14 91 ± 41* 63 ± 35
Trails B, seconds to complete 148 ± 80 144 ± 87 121 ± 61* 79 ± 29 178 ± 82* 113 ± 59 242 ± 75* 199 ± 86

Note: *P < .05; Group differences were assessed with independent t‐tests or Mann‐Whitney U tests for continuous variables and the chi‐squared statistic for categorical variables. Fisher's exact test was applied to the CDR Global variable due to low cell counts. All values represent mean ± standard deviation unless otherwise noted.

Abbreviations: APOE, apolipoprotein E; BMI, body mass index; CDR, Clinical Dementia Rating scale; GFAP, glial fibrillary acidic protein; MMSE, Mini‐Mental State Examination; NfL, neurofilament light; sCD14, soluble cluster of differentiation 14; Trails, Trail Making Test; t‐tau, total tau; UCHL1, ubiquitin carboxyl‐terminal hydrolase L1; YKL‐40, chitinase‐3‐like protein 1; WMS LM, Weschler Memory Scale Logical Memory.